Balance Labs, Inc.
BLNC
$2.11
-$0.05-2.32%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 190.30K | 189.70K | 185.90K | 152.10K | 120.50K |
| Gross Profit | -190.30K | -189.70K | -185.90K | -152.10K | -120.50K |
| SG&A Expenses | 115.40K | 94.60K | 85.30K | 59.50K | 41.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 305.80K | 284.40K | 271.30K | 211.70K | 162.50K |
| Operating Income | -305.80K | -284.40K | -271.30K | -211.70K | -162.50K |
| Income Before Tax | -463.00K | -417.60K | -528.10K | -539.20K | -415.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.46 | -0.42 | -0.53 | -0.54 | -0.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -463.00K | -417.60K | -528.10K | -539.20K | -415.10K |
| EBIT | -305.80K | -284.40K | -271.30K | -211.70K | -162.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 86.70M | 86.70M | 86.70M | 86.70M | 86.70M |
| Average Diluted Shares Outstanding | 86.70M | 86.70M | 86.70M | 86.70M | 86.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |